老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

2.85
+0.05001.79%
盤後：2.78-0.0700-2.46%16:52 EDT
成交量：32.36萬
成交額：90.68萬
市值：2.83億
市盈率：-1.97
高：2.85
開：2.83
低：2.74
收：2.80
資料載入中...
總覽公司新聞資訊公告
2021/08/03

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
更多